Study of influence of primary packaging on the stability of the original veterinary preparation
Journal Title: ScienceRise: Pharmaceutical Science - Year 2018, Vol 0, Issue 1
Abstract
<p>A great importance during the design of veterinary drugs is given to the choice of primary package, the material which is directly contact with the dosage form. Stability of samples of veterinary medicines should be investigated in packages that will be used during serial production of drugs. It is also necessary to investigate the processes that can occur with active pharmaceutical ingredients under the influence of substances contained in the packaging material. On the basis of these data, determine the shelf life of the veterinary drugs in the appropriate package.</p><p><strong>Aim.</strong> The influence of primary packaging on quality characteristics of solution based on silver citrate codenamed "Argocid", namely ampoules of 10 ml capacity and vials with a capacity of 50 ml made of light-protection glass; plastic containers (ampoules) in a capacity of 10 ml and 50 ml vials.</p><p><strong>Methods.</strong> Methods of research were conducted in accordance with the requirements of the State Pharmacopoeia of Ukraine.<strong></strong></p><p><strong>Results of the research.</strong> It was investigated that 10 ml plastic containers of Pharmalene®, 50 ml bottles of Riblene® FL 20 PH of low density polyethylene, do not cause changes in the quality of the veterinary solution regulated in the specification and allow the product to remain stable for a shelf life of 2 years. In the process of storing a silver-citrate solution of in a polymeric package of 10 ml Pharmalene® grade polyethylene occurred a volume reduction of up to 1.5 % over a period of 2 years. However, the evaporation rate of the solvent is too small for the concentration of active substances to exceed the acceptable values.</p><p><strong>Conclusions. </strong>It was established that all investigated types of containers are suitable for use as an initial packaging for the veterinary drug "Argocid", a solution for intramammary administration on the basis of silver citrate, since they allow the drug to be stable for 2 years</p>
Authors and Affiliations
Zhanna Polova, Lyudmyla Almakayeva
Keywords
Related Articles
- EP ID EP526814
- DOI 10.15587/2519-4852.2018.124449
- Views 227
- Downloads 0
Синтез та протимікробна активність амідів 3-бензил-5-метил-4-оксо-2-тіоксо-1,2,3,4-тетрагідротієно[2,3-d]піримідин-6-карбонової кислоти
<p><strong>Мета.</strong> Цілеспрямоване отримання нових протимікробних засобів серед похідних 2-тіотієно[2,3-d]піримідин-6-карбонових кислот.</p><p><strong>Матеріали та методи дослідження.</strong> У роботі використовув...
Analysis of research on the benefits of clinical and economic effectiveness, safety of innovative drug cetuximab in the treatment of colorectal cancer
<p><strong>The</strong><strong> </strong><strong>aim</strong> of the work is to analyze and systematize literature data on the benefits of clinical and economic efficiency, safety of cetuximab in the treatment of colorec...
Development of the procedure of quantitative determination of the biological active substances in the extract of a bupleurum aureum in the composition of a combined dosage form
<p>Nowadays, combined medicines are becoming more and more widespread. The combination of active pharmaceutical ingredients is necessary to increase the therapeutic effect or shorten the treatment period, or prevent poss...
The ointment containing Ag@Fe3O4 for removal and treatment of skin neoplasms
<p><strong>Aim. </strong>Priorities for improving the thermal conductivity values and the external controllability of the process of cryosurgical intervention have determined. The aim of this work is creation of soft dos...
Study of excipients quantities influencein the composition of the powder in sachet packages
<p>For developing power in sachet packages with anti-inflammatory action a special task is optimal qualitative and quantitative composition of excipients. The purpose was to study the effect of excipientʼs quantities on...